Haight Ashbury Free Clinics
San Francisco, California, 94117, United States
NCT Number: NCT00000322
The purpose of this study is to evaluate efficacy of tyrosine as a treatment for methamphetamine dependence in an outpatient treatment setting providing group psychosocial interventions. Examine effect of tyrosine on abstinence, retention in treatment, and craving."
Looking for future studies?
Notify Me18 year–65 year
All sexes
Interventional
Phase 2
San Francisco, California, 94117, United States
Evaluate efficacy of tyrosine as a treatment for methamphetamine dependence in an outpatient treatment setting providing group psychosocial interventions. Examine effect of tyrosine on abstinence, retention in treatment and craving.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
18-65 years of age. Able to provide informed consent. Desire to reduce/eliminate methamphetamine use. Used within the past two weeks. Meet DSM criteria for methamphetamine dependence.
Exclusion criteria
No dependence (within the past 12 months) for other durgs except nicotine. No history or family history of tyrosine intolerance.
National Institute on Drug Abuse (NIDA)
Nih
Tyrosine for Methamphetamine Dependence
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT01386177
Amphetamine-Related Disorders, Chemically-Induced Disorders
Basel, Switzerland
View Trial DetailsNCT01270672
Amphetamine-Related Disorders, Chemically-Induced Disorders
Basel, Switzerland
View Trial DetailsNCT01888835
Amphetamine-Related Disorders, Behavior
San Francisco, California, United States
View Trial DetailsNCT00040053
Amphetamine-Related Disorders, Chemically-Induced Disorders
Chula Vista, California, United States
View Trial Details